ORTHOPEDIATRICS CORP

KIDS

ORTHOPEDIATRICS CORP

KIDS

Insider Sentiment (TTM):

Last Purchase:2025-08-21Last Sale:2026-03-16Shares Purchased (TTM):0Shares Sold (TTM):58,171

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:15,892,048Shares Outstanding:23,685,055Institutional Ownership Pct.:67.10%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Nonrelated Party	-	48	48	0	24	24	24	15	-0	10	9	-
Related Party	-	48	48	0	24	24	24	15	-0	10	9	-
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	17	12	20	17	45	33	44	51	29	22	31	11
Restricted Cash Current	2	2	2	2	2	2	2	2	2	2	2	2
Short Term Investments	29	37	41	41	26	25	25	25	0	26	49	72
Accounts Receivable Net Current	61	54	54	51	54	44	42	43	42	36	35	38
Inventory Net	138	134	134	129	125	120	117	121	116	113	106	101
Prepaid Expense And Other Assets Current	6	7	6	6	6	8	7	6	4	5	4	4
Assets Current	253	246	256	246	258	232	237	248	194	204	226	226
Property Plant And Equipment Net	49	49	50	51	53	53	51	55	53	49	41	40
Other Assets Noncurrent
Finite Lived Intangible Assets Net	64	64	65	63	63	62	64	66	68	70	69	70
Goodwill	118	115	109	104	99	94	94	91	91	91	84	81
Indefinite Lived Intangible Assets Excluding Goodw…	13	13	13	16	17	17	17	19	19	19	15	15
Other Assets Noncurrent	15	16	16	14	14	13	10	10	6	4	3	1
Assets	511	502	509	493	504	470	473	489	431	437	439	432
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	22	20	19	7	13	14	9	12	17	20	13	23
Employee Related Liabilities Current	16	13	14	14	13	11	14	13	13	10	11	9
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	0	-
Other Short Term Borrowings	0	0	-	-	-	-	-	-	-	-	-	-
Other Liabilities Current	14	12	11	11	12	10	10	8	8	6	7	7
Liabilities Current	53	47	46	33	39	38	34	35	40	46	42	48
Long Term Notes And Loans	-	-	-	-	-	-	-	-	-	-	-	1
Liabilities Noncurrent
Convertible Long Term Notes Payable	49	49	48	48	48	48	48	48	-	-	0	-
Other Long Term Debt Noncurrent	2	3	3	2	1	1	1	0	-	-	0	-
Business Combination Contingent Consideration Liab…	-	-	-	-	-	-	-	-	-	-	0	0
Deferred Income Tax Liabilities Net	3	3	4	4	4	3	3	4	5	5	5	5
Other Liabilities Noncurrent	9	10	10	8	9	7	6	5	3	2	1	1
Liabilities Noncurrent	115	116	116	111	109	86	85	84	20	21	20	10
Liabilities	168	163	162	144	148	123	119	118	59	67	62	58
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	633	626	622	618	614	605	601	597	593	583	580	578
Retained Earnings Accumulated Deficit	-293	-286	-275	-265	-253	-246	-236	-219	-212	-206	-198	-191
Accumulated Other Comprehensive Income Loss Net Of…	3	-1	-1	-4	-5	-12	-11	-7	-10	-7	-6	-12
Stockholders Equity	344	339	347	349	356	347	355	371	371	371	377	374
Liabilities And Stockholders Equity	511	502	509	493	504	470	473	489	431	437	439	432
Allowance For Doubtful Accounts Receivable Current	2	2	2	1	1	1	1	1	1	1	1	1
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Common Stock Shares Issued	26	26	25	25	25	25	24	24	24	24	23	23
Shares Outstanding	-	-	25	-	-	-	24	-	-	-	23	23

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	17.53%	20.73%	22.94%	-	-	-	-	-	-	-	-	-
2025	-13.52%	-7.41%	-1.43%	19.33%	2.12%	-4.86%	8.44%	3.71%	11.48%	-16.02%	-12.39%	-0.60%
2024	-8.99%	-17.12%	-6.05%	17.20%	-2.93%	-5.76%	-5.49%	-16.73%	-4.00%	-3.40%	-15.89%	-18.66%
2023	-	-	-	-	-	-	11.71%	16.07%	-5.86%	5.27%	9.24%	17.47%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.78	5.21	5.55	7.40	6.66	6.19	6.98	7.17	4.90	4.45	5.44	4.72
Quick Ratio	2.06	2.23	2.53	3.34	3.26	2.79	3.33	3.49	1.84	1.88	2.81	2.54
Working Capital	199.66M	198.68M	210.22M	212.62M	219.04M	194.55M	203.21M	213.69M	154.21M	157.91M	184.83M	178.25M
Leverage & Debt
Debt to Equity	0.49	0.48	0.47	0.41	0.42	0.35	0.33	0.32	0.16	0.18	0.16	0.16
Interest Coverage TTM	-3.58	-5.25	-6.54	-8.38	-10.41	-11.66	-13.36	-15.99	-19.53	-19.03	-25.77	-45.99
Debt Ratio	0.33	0.33	0.32	0.29	0.29	0.26	0.25	0.24	0.14	0.15	0.14	0.13
Efficiency & Turnover
Asset Turnover TTM	0.50	0.50	0.48	0.46	0.47	0.47	0.45	0.41	0.40	0.37	0.34	0.33
Days Sales Outstanding TTM	82.86	73.83	74.28	75.52	79.23	68.95	68.62	77.43	79.10	71.17	72.91	81.97
Receivables Turnover TTM	4.40	4.94	4.91	4.83	4.61	5.29	5.32	4.71	4.61	5.13	5.01	4.45
Per Share Metrics
Diluted EPS TTM	-1.65	-1.68	-1.69	-1.94	-1.78	-1.75	-1.64	-1.23	-1.09	-0.96	-0.92	-0.97
Free Cash Flow Per Share TTM	-0.22	-0.60	-0.75	-0.98	-1.34	-1.60	-1.81	-2.11	-2.09	-2.00	-1.94	-1.60
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	73.65%	73.07%	73.05%	71.73%	71.54%	72.81%	72.58%	73.68%	74.62%	74.07%	74.80%	74.42%
Operating Profit Margin TTM	-11.87%	-15.04%	-16.60%	-19.84%	-18.69%	-17.07%	-17.10%	-15.30%	-15.97%	-17.23%	-17.99%	-18.99%
Net Profit Margin TTM	-15.72%	-16.31%	-16.78%	-20.06%	-18.92%	-19.15%	-18.47%	-15.00%	-14.35%	-13.58%	-14.10%	-15.57%
Growth Metrics
Net Revenue Growth (1Y)	14.49%	14.52%	15.45%	19.90%	26.08%	31.28%	37.65%	33.47%	27.70%	24.04%	21.62%	22.40%
Net Income Growth (1Y)	-4.87%	-2.46%	4.83%	60.36%	66.27%	85.12%	80.33%	28.53%	-2,614.11%	-718.61%	-1,767.25%	-341.13%
EPS Growth (1Y)	-7.20%	-4.33%	3.12%	57.68%	64.04%	81.85%	77.19%	26.26%	-2,566.28%	-710.08%	-1,622.33%	-324.05%
Valuation Metrics
P/E TTM	-11.58	-9.47	-10.51	-9.57	-12.07	-14.07	-14.14	-22.08	-26.50	-30.29	-35.15	-32.91
P/B TTM	1.34	1.11	1.20	1.25	1.42	1.65	1.51	1.69	1.79	1.80	1.96	1.95
P/S TTM	1.82	1.54	1.76	1.92	2.28	2.69	2.61	3.31	3.80	4.11	4.96	5.13
Market Cap	460.05M	375.88M	416.64M	436.67M	503.92M	572.18M	534.94M	628.17M	665.65M	665.45M	737.18M	728.41M
Enterprise Value	489.80M	410.28M	443.51M	466.12M	505.49M	584.79M	537.08M	622.96M	634.76M	641.89M	704.30M	716.18M
Calculated Values
Free Cash Flow TTM	-5.17M	-14.19M	-17.53M	-23.14M	-31.38M	-37.07M	-41.84M	-48.97M	-48.45M	-45.67M	-43.92M	-36.41M
Net Debt	29.75M	34.40M	26.87M	29.44M	1.56M	12.61M	2.14M	-5.21M	-30.89M	-23.56M	-32.88M	-12.23M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-16Sale

Owner: Gerritzen, Daniel J

Title: General Counsel and Secretary

Shares: 8,614

Price/Share: $17.25

Value: $148,591.50

Shares Owned: 149,533

Relationship: Officer

Ownership: Direct

2026-03-16Sale

Owner: Hauser, Joseph W

Title: Pres. Trauma & Def. Correction

Shares: 8,596

Price/Share: $17.25

Value: $148,281.00

Shares Owned: 194,767

Relationship: Officer

Ownership: Direct

2026-03-16Sale

Owner: Bailey, David R

Title: President and CEO

Shares: 19,535

Price/Share: $17.25

Value: $336,978.75

Shares Owned: 298,020

Relationship: Director,Officer

Ownership: Direct

2026-03-16Sale

Owner: Odle, Gregory A

Title: President of Scoliosis

Shares: 8,433

Price/Share: $17.25

Value: $145,469.25

Shares Owned: 187,735

Relationship: Officer

Ownership: Direct

2026-03-16Sale

Owner: Hite, Fred

Title: COO and CFO

Shares: 12,993

Price/Share: $17.25

Value: $224,129.25

Shares Owned: 277,477

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-16	Gerritzen, Daniel J	Officer	General Counsel and Secretary	Direct	Sale	8,614	17.25	$148,591.50	149,533	4
2026-03-16	Hauser, Joseph W	Officer	Pres. Trauma & Def. Correction	Direct	Sale	8,596	17.25	$148,281.00	194,767	4
2026-03-16	Bailey, David R	Director,Officer	President and CEO	Direct	Sale	19,535	17.25	$336,978.75	298,020	4
2026-03-16	Odle, Gregory A	Officer	President of Scoliosis	Direct	Sale	8,433	17.25	$145,469.25	187,735	4
2026-03-16	Hite, Fred	Director,Officer	COO and CFO	Direct	Sale	12,993	17.25	$224,129.25	277,477	4
2025-08-21	Hite, Fred	Director,Officer	COO and CFO	Direct	Purchase	5,076	19.41	$98,525.16	213,065	4
2025-03-18	Bailey, David R	Director,Officer	President and CEO	Direct	Sale	6,620	24.86	$164,573.20	319,155	4
2025-03-18	Gerritzen, Daniel J	Officer	General Counsel and Secretary	Direct	Sale	5,310	24.86	$132,006.60	110,767	4
2025-03-18	Hite, Fred	Director,Officer	COO and CFO	Direct	Sale	6,443	24.86	$160,172.98	207,989	4
2025-03-18	Hauser, Joseph W	Officer	Pres. Trauma & Def. Correction	Direct	Sale	5,300	24.86	$131,758.00	137,663	4
2025-03-18	Odle, Gregory A	Officer	President of Scoliosis	Direct	Sale	5,359	24.86	$133,224.74	148,788	4
2024-08-21	Gerritzen, Daniel J	Officer	General Counsel and Secretary	Direct	Sale	10,000	29.30	$293,000.00	77,304	4
2024-03-11	Odle, Gregory A	Officer	President of Scoliosis	Direct	Sale	2,768	27.59	$76,369.12	80,473	4
2024-03-11	Gerritzen, Daniel J	Officer	General Counsel and Secretary	Direct	Sale	2,741	27.59	$75,624.19	52,403	4
2024-03-11	Hite, Fred	Director,Officer	COO and CFO	Direct	Sale	3,195	27.59	$88,150.05	94,072	4
2024-03-11	Throdahl, Mark C	Director	-	Direct	Sale	2,433	27.59	$67,126.47	137,857	4
2024-03-11	Bailey, David R	Director,Officer	President and CEO	Direct	Sale	3,213	27.59	$88,646.67	139,384	4
2024-02-22	Hauser, Joseph W	Officer	Pres. Trauma & Def. Correction	Direct	Sale	2,903	28.06	$81,458.18	52,858	4
2023-08-11	Schlotterback, Terry D	Director	-	Direct	Sale	2,610	38.25	$99,832.50	15,452	4
2023-06-26	Hite, Fred	Director,Officer	COO and CFO	Direct	Sale	4,356	43.69	$190,313.64	97,267	4
2023-04-27	Odle, Gregory A	Officer	President of Scoliosis	Direct	Sale	3,333	50.10	$166,983.30	83,241	4
2023-04-25	Odle, Gregory A	Officer	President of Scoliosis	Direct	Sale	828	50.02	$41,416.56	86,574	4
2023-04-21	Odle, Gregory A	Officer	President of Scoliosis	Direct	Sale	644	50.02	$32,212.88	87,402	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

67.10%

Inst. Shares: 15,892,048

Shares Outstanding: 23,685,055

2025-12-31

68.04%

Inst. Shares: 15,962,716

Shares Outstanding: 23,459,425

2025-09-30

68.90%

Inst. Shares: 16,236,182

Shares Outstanding: 23,565,779

2025-06-30

67.57%

Inst. Shares: 15,852,873

Shares Outstanding: 23,460,144

2025-03-31

68.60%

Inst. Shares: 15,935,303

Shares Outstanding: 23,230,871

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	15,892,048	23,685,055	67.10%
2025-12-31	15,962,716	23,459,425	68.04%
2025-09-30	16,236,182	23,565,779	68.90%
2025-06-30	15,852,873	23,460,144	67.57%
2025-03-31	15,935,303	23,230,871	68.60%
2024-12-31	15,625,247	23,077,704	67.71%
2024-09-30	15,495,157	23,171,249	66.87%
2024-06-30	15,549,563	23,145,064	67.18%
2024-03-31	14,910,628	22,820,779	65.34%
2023-12-31	15,450,138	22,675,477	68.14%
2023-09-30	15,437,007	22,762,823	67.82%
2023-06-30	15,259,713	22,704,723	67.21%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

ORTHOPEDIATRICS CORP (KIDS) — SEC Financial Statements & Analysis

ORTHOPEDIATRICS CORP (KIDS) is a surgical & medical instruments & apparatus company. ORTHOPEDIATRICS CORP trades on Nasdaq as: KIDS. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), ORTHOPEDIATRICS CORP reported a 14.49% year-over-year revenue growth, a Gross Profit Margin of 73.65% (TTM), a Debt-to-Equity ratio of 0.49x, a Price-to-Sales (P/S) ratio of 1.82x (TTM), a Price-to-Book (P/B) ratio of 1.34x (TTM), at a market cap of $460.05M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 14.49%
Gross Profit Margin TTM: 73.65%
Debt To Equity: 0.49x
P/S TTM: 1.82x
P/B TTM: 1.34x
Market Cap: $460.05M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ORTHOPEDIATRICS CORP in?

ORTHOPEDIATRICS CORP (KIDS) operates in the Surgical & Medical Instruments & Apparatus industry.

What is KIDS's market cap?

ORTHOPEDIATRICS CORP (KIDS) has a market capitalization of $460.05M as of 2026-06-30.

What exchange does KIDS trade on?

ORTHOPEDIATRICS CORP (KIDS) trades on the Nasdaq.